|
Contact
|
Newsletter
|
Sitemap
|
Deutsch
»
Bayer Group
Home
Subgroups
Bayer AG (Holding Company)
Bayer HealthCare
Bayer CropScience
Bayer MaterialScience
Bayer Business Services
Bayer Technology Services
Currenta
Topics
Business & Finance
Research & Innovation
Products
Responsible Care
Social Responsibility
Bayer People
Europe
North America
Asia & Pacific
Central-/Latin America
Africa & Middle East
Press Contact
Bayer AG
(Holding Company)
Bayer HealthCare
Bayer CropScience
Bayer MaterialScience
Bayer Business Services
Bayer Technology Services
Photo-Service
Biographies
Board of Management
Subgroup Management Boards
Supervisory Board
Speeches
Photos
Bayer AG (Holding Company)
Bayer HealthCare
Bayer CropScience
Bayer MaterialScience
Bayer Business Services
Bayer Technology Services
Currenta
Education and Training
Research
Locations
Environmental Protection
BayKomm
TV Service
Bayer AG (Holding Company)
Bayer HealthCare
Bayer CropScience
Bayer MaterialScience
Bayer Business Services
Bayer Technology Services
Currenta
Education and Training
Research
Locations
Environmental Protection
BayKomm
Bayer Links
Bayer Global
Bayer HealthCare
Bayer CropScience
Bayer MaterialScience
Bayer Business Services
Bayer Technology Services
Currenta
Special Interest
Investor Relations
Jobs and Career
Foundations
Sports
Culture
Photos
Bayer HealthCare
|
1 - 15
|
1960 KB
Bayer HealthCare’s research site in Berlin, Germany.
1463 KB
Bayer HealthCare’s research site in Wuppertal, Germany.
1784 KB
Scientists are comparing the pictures of a healthy brain (left display) with the picture of a brain of an Alzheimer patient.
1309 KB
The scientists at Bayer HealthCare are looking for new therapeutic approaches to heart disease. Virtual representations of molecules help them to find the ideal binding point for a potential active ingredient.
1974 KB
Scientists at Bayer are focusing on novel substances to treat serious heart and lung diseases. Their efforts have met with success, and the first promising compounds for the treatment of pulmonary hypertension and heart failure are at an advanced stage of clinical development.
1287 KB
Personalized medicine is based on a precise definition of the nature and status of the disease in question. This is the only way to find out which patients will benefit most from a therapy, whether adverse effects are likely to occur, and even if the therapy is likely to work at all.
1287 KB
Testing of new formulations of the Aspirin substances at the laboratories of Bayer HealthCare in Morristown, New Jersey, USA.
1829 KB
Tests on new formulations of the active ingredient acetylsalicylic acid in the Product Development Center in Morristown, New Jersey.
1471 KB
Systematic search for active ingredients: using bioanalytical methods, scientists investigate how pharmaceutical substances can be used to improve the regulation of the hormonal balance and thus help relieve the symptoms of endometriosis or fibroids.
1656 KB
In the Department Nuclear Medicine of Leipzig University Hospital (Director and Chairman: Univ.-Prof. Dr. med. O. Sabri) scientists prepare the manufacture of florbetaben in what are known as hot cells. Radiosynthesis of this substance, which enables doctors to detect potential Alzheimer's triggers in the brains of patients, takes place inside these units.
1001 KB
New potential drugs for cardiological indications are passing through first clinical trials.
302 KB
Bayer's Contour for individuell diabetes management makes blood glucose monitoring simple.
492 KB
Bayer's Contour USB with plug & play diabetes management software helps transform individual blood glucose results into meaningful insights.
956 KB
Together a veterinarian and a farmer look after a piglet. Healthy animals are essential for food safety. Therefore Bayer continually conducts research on new active ingredients and formulations.
1372 KB
The protection against parasitic pests is important. Pet owners should contact their veterinarian and protect their pets against parasites.
|
1 - 15
|
Copyright @ Bayer AG
General Conditions of Use
-
Privacy Statement
-
Imprint
Print page
Search
Advanced Search
Publications
Stockholders' Newsletter
Sustainable Development Report
Annual Report
Publications Overview
Newsletter
We will keep you informed about the latest news.
Events
Tuesday, February 28, 2012
Financial News Conference Full Year 2011
Contact:
Günter Forneck
Additional Press Events
Investor Relations Events
BayKomm Events
Download Center - Selection
Your selection:
0
Download(s)